Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 11, 2015 - Issue 4
Submit an article Journal homepage
418
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders

Alfredo Carlo AltamuraUniversity of Milan, Department of Psychiatry, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, 20122, Milan, [email protected]
, MD,
Alice CaldiroliUniversity of Milan, Department of Psychiatry, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, 20122, Milan, [email protected]
, MD &
Massimiliano BuoliUniversity of Milan, Department of Psychiatry, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, 20122, Milan, [email protected]
, MD
Pages 649-660 | Published online: 01 Mar 2015

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Massimiliano Buoli, Silvia Grassi, Marta Serati & A. Carlo Altamura. (2017) Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 18:13, pages 1373-1379.
Read now
Massimiliano Buoli, Alice Caldiroli & Marta Serati. (2017) Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 351-359.
Read now
Massimiliano Buoli, Marta Serati, Valentina Ciappolino & A. Carlo Altamura. (2016) May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?. Expert Opinion on Pharmacotherapy 17:10, pages 1375-1385.
Read now

Articles from other publishers (11)

Ding‐ping She, Ying He, Ming‐qu Li, Li Su, Di Ren, Xiao‐han Huang, Yu‐Hua Zhang, Hai‐tang Hu, De‐cheng Deng & Jian‐long Wu. (2023) Pharmacokinetics and bioequivalence studies of fluvoxamine maleate tablets in healthy Chinese subjects. Biomedical Chromatography 37:6.
Crossref
Naif A Arishi, Naif M Althomali, Ibrahim M Dighriri, Mohammed S Alharthi, Ghadeer B Alqurashi, Razan A Musharraf, Aeshah H Albuhayri, Marwah k Almalki, Shatha A Alnami & Zamzam O Mashraqi. (2023) An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment. Cureus.
Crossref
Michele Bartoletti, Ozlem Azap, Aleksandra Barac, Linda Bussini, Onder Ergonul, Robert Krause, Alejandro Martin-Quiros, José Ramón Paño-Pardo, Nicholas Power, Marcella Sibani, Balint Gergely Szabo, Sotirios Tsiodras, Ines Zollner-Schwetz & Jesús Rodríguez-Baño. (2022) European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease. Clinical Microbiology and Infection 28:12, pages 1578-1590.
Crossref
Mahsa Asadi Anar, Elaheh Foroughi, Elika Sohrabi, Samira Peiravi, Yasaman Tavakoli, Mozhgan Kameli Khouzani, Parisa Behshood, Melika Shamshiri, Arezoo Faridzadeh, Kimia Keylani, Seyedeh Faride Langari, Akram Ansari, Amirmohammad Khalaji, Setareh Garousi, Mehran Mottahedi, Sara Honari & Niloofar Deravi. (2022) Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19. Frontiers in Pharmacology 13.
Crossref
Simeng Gu, Zhengming He, Qiuyue Xu, Jie Dong, Tingwei Xiao, Fei Liang, Xianjun Ma, Fushun Wang & Jason H. Huang. (2022) The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression. Frontiers in Psychiatry 13.
Crossref
Isabelle Bazin & Marion Desmarchelier. (2022) Retrospective study on the use of fluvoxamine in 72 dogs with anxiety disorders. Journal of Veterinary Behavior 50, pages 60-69.
Crossref
Pascal Le Corre & Gwenolé Loas. (2022) Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection. Frontiers in Pharmacology 13.
Crossref
Shelley N. Facente, Angela M. Reiersen, Eric J. Lenze, David R. Boulware & Jeffrey D. Klausner. (2021) Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs 81:18, pages 2081-2089.
Crossref
Yang Du, Biao Du, Yun Diao, Zubin Yin, Jin Li, Yunfeng Shu, Zizhen Zhang & Lizhi Chen. (2021) Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis. Asian Journal of Psychiatry 60, pages 102664.
Crossref
Kei Odai, Tohru Sugimoto & Etsuro Ito. (2020) Quantum chemical calculation of intrinsic reaction coordinates from trans to cis structure of fluvoxamine. Computational and Theoretical Chemistry 1192, pages 113051.
Crossref
Elizabeth A. Crocco, Sindy Jaramillo, Caroline Cruz-Ortiz & Katherine Camfield. (2017) Pharmacological Management of Anxiety Disorders in the Elderly. Current Treatment Options in Psychiatry 4:1, pages 33-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.